Skip to Content
Return to Navigation

Sanofi, A Straggler In The Covid-19 Vaccine Race, Accelerates Its Plans-STAT, 6/23

The drug maker Sanofi Pasteur has been more cautious than some of its rivals in projecting when its Covid-19 vaccines might be ready. Now, it’s announcing an acceleration of clinical trials to reach the market faster — and striking a $425 million deal to broaden its partnership with a smaller biotech company to develop one of them. STAT, 06/23/2020

Share this article: